» FVIII Immunodepleted Deficient Human Plasma with VWF

HEMOSTASIS COAGULATION RESEARCH DEFICIENT PLASMAS IMMUNODEPLETED DEFICIENT PLASMAS

FVIII Immunodepleted Deficient Human Plasma with VWF

Fresh Frozen Plasmas

Human plasma immunodepleted of Factor VIII with a normal level of Factor von Willebrand (VWF), used for the search for inhibitors of Factor VIII. Frozen and poor in platelets.
Human FVIII deficient plasma is produced from a pool of human normal citrated plasma, immunodepleted to obtain a deficiency in factor VIII with VIII levels (antigen and activity) <1% while VWF levels (antigen and activity) are >50%.

Reference	6-FDPFVIII-VWF
Presentation	Bottle
Format	1 x 100 mL
Quote

Reference	6-FDPFVIII-VWF-50
Presentation	Bottle
Format	1 x 50 mL
Quote

Reference	6-FDPFVIII-VWF-500
Presentation	Bottle
Format	1 x 500 mL
Quote

Price list, safety data sheets and notices are accessible to our registered customers.

Reference	Presentation	Format
6-FDPFVIII-VWF	Bottle	1 x 100 mL
6-FDPFVIII-VWF-50	Bottle	1 x 50 mL
6-FDPFVIII-VWF-500	Bottle	1 x 500 mL

Price list, safety data sheets and notices are accessible to our registered customers.

Factor VIII is a glycoprotein with a molecular weight of 250,000 Da synthesized mainly by the liver.
It circulates in the plasma in the form bound to VWF which protects it from rapid proteolytic degradation.
It is activated by FXa or thrombin in FVIIIa which will complex with FIXa in the presence of phospholipids to activate FX in FXa. A patient who is deficient in FVIII has hemophilia A.

Frozen, immuno-depleted plasmas are certified to have less than 1% for the element considered, both for the antigenic and functional assay in haemostasis. Intended for research use.

- No bovine additives
- No reconstitution error
- No plasma alteration linked to freeze-drying

- 1 bottle of minimum 100 mL of frozen plasma.

	These kits are manufactured in accordance with the 98/79 EC directive for in vitro diagnostic devices. Only CE marked products can be used for diagnostic applications in Europe.
	These kits are intended for in vitro diagnostic use.
	These kits are for research use only and are not intended to be used for diagnostic procedures.
	Federal Drug Administration, FDA validates diagnostic kits for in vitro diagnostic use in the United States.
	Biological risk products.
	Storage between 2 and 8 ° C.
	Reactive in liquid form.
	Reactive in lyophilized form.
	Reactive in frozen form.
	Stability after opening at 2-8 ° C.
	Products that can be refrozen.
	Stability 12 months after refreezing at -20 ° C.
	Manufacturer.
	Importer
	Distributor.

HEMOSTASIS COAGULATION RESEARCH DEFICIENT PLASMAS IMMUNODEPLETED DEFICIENT PLASMAS